Multiple Symptoms Study 3 – An extended-role general practitioner clinic for patients with persistent physical symptoms: a Randomised Controlled Trial
Authors:
- Christopher BurtonCBChristopher Burton
- Cara MooneyCMCara Mooney
- Laura SuttonLSLaura Sutton
- David WhiteDWDavid White
- Jeremy DawsonJDJeremy Dawson
- Kate FryerKFKate Fryer
- Monica GrecoMGMonica Greco
- Michelle HorspoolMHMichelle Horspool
- Aileen NeilsonANAileen Neilson
- Gillian RowlandsGRGillian Rowlands
- Tom SandersTSTom Sanders
- Ruth ThomasRTRuth Thomas
Open Access
- 1 April 2025
- journal article
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- p. 1-24
Abstract
Background: People with multiple and persistent physical symptoms have impaired quality of life and poor experiences of health care. We aimed to evaluate the effectiveness of a community-based Symptoms Clinic intervention in people with multiple and persistent physical symptoms. Trial design: Pragmatic multicentre individually randomised parallel group clinical trial. Methods: Participants: Recruitment was between December 2018 and December 2021 in four areas of the UK. Eligibility was based on electronic health records, healthcare use and multiple physical symptoms (PHQ-15 between 10 and 20) which were not due to other medical conditions. Intervention delivery changed from face to face to online in 2020 in response to the pandemic. Interventions: Participants were randomised to receive the Symptoms Clinic plus usual care (intervention) or usual care alone (control). The Symptoms Clinic is a short-term extended medical consultation-based intervention delivered over approximately 8 weeks. Objective: To test the clinical and cost-effectiveness of an extended-role general practitioner ‘Symptoms Clinic’ for people with persistent physical symptoms. Outcome: The primary outcome measure was the PHQ-15 at 52 weeks post randomisation. Randomisation: Participants were randomised 1 : 1 using a centralised web-based system, stratified by study centre with random permuted blocks of varying sizes. Masking: It was not possible to mask participants to their allocation. Outcome assessors who handled patient-reported questionnaires were masked to allocation. Results: Numbers randomised: 354 participants were randomised into the trial: 176 to the usual care group and 178 to the intervention group. Numbers analysed: 132 participants in the usual care group and 144 participants in the intervention group were included in the analysis representing 77.8% retention. Outcome: Mean (SD) PHQ-15 at baseline was 14.9 (3.0) in the control group and 15.0 (2.9) in the intervention group. At 52 weeks it was 14.1 (3.7) in the control group and 12.2 (4.5) in the intervention group. The between-group difference, adjusted for age, sex, baseline PHQ-15 and clinician effect was −1.82 (95% CI −2.67 to −0.97; p < 0.001) favouring the intervention. Harms: There were no significant between-group differences in the proportions of patients experiencing non-serious (−0.03, 95% CI −0.11 to 0.05) or serious (0.02, 95% CI −0.02 to 0.07) adverse events. All serious adverse events were deemed unrelated to trial interventions. Economic evaluation: Cost-effectiveness analysis indicated an incremental cost-effectiveness ratio of £15,751/QALY. Process evaluation: The intervention was delivered with high fidelity and was acceptable to patients. The intervention appeared to act through the hypothesised mechanism of explanation as a bridge from uncertainty about the cause to actions to manage symptoms. Limitations and further research: The intervention was delivered by a small number of GPs in long consultations. Further research should examine wider implementation and how to integrate elements of the intervention into shorter consultations. Conclusions: The Symptoms Clinic delivered by specially trained GPs leads to a clinically meaningful improvement in physical symptoms at 52 weeks and is likely to be a cost-effective addition to current care. Funding: This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme as award number 15/136/07.Keywords
Funding Information
- Health and Social Care Delivery Research (HSDR) Programme (15/136/07)
This publication has 86 references indexed in Scilit:
- The hermeneutics of symptomsMedicine, Health Care and Philosophy, 2022
- What is the Prevalence of Low Health Literacy in European Union Member States? A Systematic Review and Meta-analysisJournal of General Internal Medicine, 2021
- Reassurance After Diagnostic Testing With a Low Pretest Probability of Serious DiseaseJAMA Internal Medicine, 2013
- Development of a self-report measure of capability wellbeing for adults: the ICECAP-AQuality of Life Research, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom SeverityArthritis Care & Research, 2010
- The cognitive behavioural model of medically unexplained symptoms: A theoretical and empirical reviewClinical Psychology Review, 2007
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Psychosocial interventions for somatizing patients by the general practitionerJournal of Psychosomatic Research, 2004
- The role of gender in fibromyalgia syndromeCurrent Rheumatology Reports, 2001